ClinicalTrials.gov
ClinicalTrials.gov Menu

Primary Rituximab and Maintenance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00140582
Recruitment Status : Completed
First Posted : September 1, 2005
Last Update Posted : March 13, 2017
Sponsor:
Collaborators:
HOVON - Dutch Haemato-Oncology Association
German Low Grade Lymphoma Study Group (GLSG/OSHO)
Australasian Leukaemia and Lymphoma Group
Institute of Cancer Research, United Kingdom
Information provided by (Responsible Party):
Lymphoma Study Association

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2007
  Actual Study Completion Date : December 2016
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):